Neuralia TMS Spotlights TMS Therapy Availability at Its Kardinya Location

Australia, 25th Sep 2026 – Neuralia TMS, a trusted mental health service provider, has announced that Transcranial Magnetic Stimulation therapy is available at its Kardinya location. The announcement covers access to TMS therapy for patients in the Kardinya area and surrounding suburbs.

Neuralia TMS offers TMS therapy, a non-invasive, drug-free treatment used for conditions including depression, anxiety, PTSD, OCD, chronic pain, and Parkinson’s disease. The clinic also provides transcranial Direct Current Stimulation, an at-home neuromodulation therapy, and pharmacogenetic testing to help tailor treatment based on a patient’s individual genetic profile. TMS therapy at the Kardinya location is available to patients referred through the standard assessment process the clinic follows for new patients.

TMS therapy uses magnetic pulses directed at specific areas of the brain, and is delivered as a course of sessions rather than a single treatment. Neuralia TMS said patients considering TMS therapy typically undergo an initial assessment with the clinic’s medical team before a treatment plan is developed, since suitability for TMS depends on a patient’s individual history and circumstances. The clinic’s pharmacogenetic testing is available to patients as part of this broader assessment process, where genetic information can help inform treatment decisions.

Patients are generally referred to Neuralia TMS by a general practitioner or psychiatrist, and the clinic’s medical team reviews each referral before an initial consultation is arranged. Neuralia TMS said the Kardinya location follows the same referral and assessment process used across its other locations, so patients in the area are not required to follow a different pathway to access care.

A TMS treatment course is delivered over a series of sessions scheduled across several weeks, and Neuralia TMS said the clinic works with each patient on a schedule that fits around their other commitments where possible. The clinic’s medical team monitors patients throughout a course of treatment, with the treatment plan reviewed and adjusted as sessions continue based on each patient’s individual circumstances.

“Having TMS therapy available at the Kardinya location means patients in the area do not need to travel further to access this type of treatment,” said Dr Shanek Wick, Medical Director of Neuralia TMS. “Every patient goes through an individual assessment before starting TMS, since it is not something offered as a standard treatment for every patient who asks about it.”

Neuralia TMS’s Kardinya location offers the same range of services provided across the clinic’s other locations, including TMS therapy, tDCS, and pharmacogenetic testing. The clinic said patients are supported by its clinical team throughout a course of TMS sessions, with treatment plans reviewed as sessions progress. Access to TMS therapy at Kardinya is intended to reduce travel distance for patients in the local area who would otherwise need to attend a clinic further away.

“Looking ahead, the clinic intends to keep TMS therapy available at the Kardinya location as part of its broader service across the areas it operates in,” Dr Wick said. “Neuralia TMS expects continued interest from patients in the Kardinya area seeking an assessment for TMS therapy or the clinic’s other services.”

Neuralia TMS is a mental health service provider offering TMS therapy, tDCS, and pharmacogenetic testing, with a location in Kardinya, Western Australia. The clinic’s services are used for conditions including depression, anxiety, PTSD, OCD, chronic pain, and Parkinson’s disease. The announcement regarding TMS therapy availability at Kardinya reflects the clinic’s ongoing work supporting patients across the areas it serves.

For additional information about TMS Kardinya services and related industry developments, contact Neuralia TMS at Unit 12, 17-23 South Street, Kardinya, WA 6163. Inquiries regarding the clinic’s services and appointments can be directed to 08 6243 0348 or by email at info@neuralia.com.au.

Media Contact

Organization: Neuralia TMS Kardinya

Contact Person: Dr Shanek Wick

Website: https://www.neuraliatms.com.au/

Email: Send Email

Contact Number: +6162430348

Address: Unit 12, 17-23 South Street, Kardinya, WA 6163

Country: Australia

Release id: 49461

The post Neuralia TMS Spotlights TMS Therapy Availability at Its Kardinya Location appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

Post Disclaimer

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Wisconsin Beacon journalist was involved in the writing and production of this article.